"Hypoxic ischemic encephalopathy" trang 1 - tải miễn phí từ tailieunhanh
Benefits of starting hypothermia treatment within 6 h vs. 6–12 h in newborns with moderate neonatal hypoxic-ischemic encephalopathy

Benefits of starting hypothermia treatment within 6 h vs. 6–12 h in newborns with moderate neonatal hypoxic-ischemic encephalopathy
8    56    0
Early clinical signs in neonates with hypoxic ischemic encephalopathy predict an abnormal amplitude-integrated electroencephalogram at age 6 hours

Early clinical signs in neonates with hypoxic ischemic encephalopathy predict an abnormal amplitude-integrated electroencephalogram at age 6 hours
11    72    0
Severity of hypoxic ischemic encephalopathy and heart rate variability in neonates: A systematic review

Severity of hypoxic ischemic encephalopathy and heart rate variability in neonates: A systematic review
12    79    0
Melatonin alleviates brain and peripheral tissue edema in a neonatal rat model of hypoxic-ischemic brain damage: The involvement of edema related proteins

Melatonin alleviates brain and peripheral tissue edema in a neonatal rat model of hypoxic-ischemic brain damage: The involvement of edema related proteins
13    89    0
Safety and efficacy of topiramate in neonates with hypoxic ischemic encephalopathy treated with hypothermia (NeoNATI)

Safety and efficacy of topiramate in neonates with hypoxic ischemic encephalopathy treated with hypothermia (NeoNATI)
11    64    0
Combination therapy with erythropoietin, magnesium sulfate and hypothermia for hypoxic-ischemic encephalopathy: An open-label pilot study to assess the safety and feasibility

Combination therapy with erythropoietin, magnesium sulfate and hypothermia for hypoxic-ischemic encephalopathy: An open-label pilot study to assess the safety and feasibility
6    97    0
Practice variation in anti-epileptic drug use for neonatal hypoxic-ischemic encephalopathy among regional NICUs

Practice variation in anti-epileptic drug use for neonatal hypoxic-ischemic encephalopathy among regional NICUs
13    68    0
Prevalence, severity and early outcomes of hypoxic ischemic encephalopathy among newborns at a tertiary hospital, in northern Tanzania

Prevalence, severity and early outcomes of hypoxic ischemic encephalopathy among newborns at a tertiary hospital, in northern Tanzania
6    99    0
Early identification of brain injury in infants with hypoxic ischemic encephalopathy at high risk for severe impairments: Accuracy of MRI performed in the first days of life

Early identification of brain injury in infants with hypoxic ischemic encephalopathy at high risk for severe impairments: Accuracy of MRI performed in the first days of life
7    72    0
LyTONEPAL: Long term outcome of neonatal hypoxic encephalopathy in the era of neuroprotective treatment with hypothermia: A French population-based cohort

LyTONEPAL: Long term outcome of neonatal hypoxic encephalopathy in the era of neuroprotective treatment with hypothermia: A French population-based cohort
8    80    0
Effect of allopurinol in addition to hypothermia treatment in neonates for hypoxic-ischemic brain injury on neurocognitive outcome (ALBINO): Study protocol of a blinded randomized placebocontrolled parallel group multicenter trial for superiority (phase III)

Effect of allopurinol in addition to hypothermia treatment in neonates for hypoxic-ischemic brain injury on neurocognitive outcome (ALBINO): Study protocol of a blinded randomized placebocontrolled parallel group multicenter trial for superiority (phase III)
10    70    0
Prognostic value of early, conventional proton magnetic resonance spectroscopy in cooled asphyxiated infants

Prognostic value of early, conventional proton magnetic resonance spectroscopy in cooled asphyxiated infants
11    85    0
COVID-19-associated apnea and circumoral cyanosis in a 3-week-old

COVID-19-associated apnea and circumoral cyanosis in a 3-week-old
3    72    1